CVS Health Corporation (CVS) To Go Ex-Dividend on July 23rd

CVS Health Corporation (NYSE:CVS) announced a quarterly dividend on Friday, July 10th. Investors of record on Thursday, July 23rd will be given a dividend of 0.665 per share by the pharmacy operator on Monday, August 3rd. This represents a c) annualized dividend and a dividend yield of 2.5%. The ex-dividend date is Thursday, July 23rd.

CVS Health has increased its dividend by an average of 0.1%per year over the last three years and has increased its dividend every year for the last 4 years. CVS Health has a dividend payout ratio of 37.7% meaning its dividend is sufficiently covered by earnings. Equities analysts expect CVS Health to earn $8.39 per share next year, which means the company should continue to be able to cover its $2.66 annual dividend with an expected future payout ratio of 31.7%.

CVS Health Price Performance

CVS opened at $107.49 on Tuesday. The stock’s 50-day moving average price is $99.28 and its 200 day moving average price is $85.36. CVS Health has a 12-month low of $58.50 and a 12-month high of $108.97. The firm has a market cap of $137.15 billion, a price-to-earnings ratio of 47.35, a PEG ratio of 1.05 and a beta of 0.61. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share for the quarter, beating the consensus estimate of $2.21 by $0.36. The company had revenue of $100.43 billion during the quarter, compared to the consensus estimate of $94.99 billion. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.CVS Health’s revenue was up 6.2% compared to the same quarter last year. During the same period in the previous year, the company posted $2.25 EPS. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. As a group, sell-side analysts expect that CVS Health will post 7.46 earnings per share for the current year.

Analyst Upgrades and Downgrades

CVS has been the topic of a number of research reports. Argus increased their target price on shares of CVS Health from $90.00 to $104.00 and gave the stock a “buy” rating in a report on Thursday, May 14th. UBS Group upped their price objective on CVS Health from $100.00 to $115.00 and gave the stock a “buy” rating in a research report on Monday, June 8th. Sanford C. Bernstein increased their price objective on CVS Health from $94.00 to $106.00 and gave the company an “outperform” rating in a research note on Tuesday, May 12th. HSBC reiterated a “hold” rating and issued a $103.00 target price on shares of CVS Health in a report on Monday, July 6th. Finally, Wall Street Zen downgraded CVS Health from a “buy” rating to a “hold” rating in a report on Wednesday, July 15th. Twenty-one investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $105.38.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.